Mergers & Acquisitions

Noxafil is an azole antifungal agent.

The value-based collaboration provides preferred access to integrated multidisciplinary care for digestive conditions.

Fluphenazine hydrochloride tablets are used to treat symptoms of schizophrenia.

The infusion clinic is referral-based and will provide treatments for rheumatology, gastroenterology, pulmonary, neurology, dermatology, oncology and other chronic conditions.

L’Oréal signed an agreement with Natura &Co. to acquire the luxury Australian beauty brand Aēsop.

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines.

Under the terms of the transaction, each outstanding share of Signify Health common stock is being exchanged for $30.50 in cash, representing a total transaction value of approximately $8 billion.

WBA's U.S. healthcare segment's businesses grew sales at a combined rate of 30% in the quarter.